Evaluating the cost-benefit profile of CPI stem cell therapy requires a comprehensive approach. Supporters often highlight the potential for substantial therapeutic outcomes, especially in diseases where conventional medications have proven limited. However, crucially important to assess the significant financial investment associated with CPI stem